Search Results 21-30 of 16586 for B cell lymphomas
Developing the Lymph2Cx genetic test to help guide the diagnosis and treatment of people with diffuse large B-cell lymphoma, the most common type of non- ...
Dose-Reduced Consolidation Radiation Therapy in Patients With Diffuse Large B-cell Lymphoma (DLBCL) · Overview · Participation eligibility · Participating Mayo ...
A Study of Copanlisib and Nivolumab in Treating Participants With Recurrent or Refractory Diffuse Large B-cell Lymphoma or Primary Mediastinal Large B-cell ...
DNA Sequencing-Based Monitoring of Minimal Residual Disease to Predict Relapse in Aggressive B-cell Non-Hodgkin Lymphomas · Overview · Participation eligibility.
It targets the B-cell lymphoma 2 (BCL-2) protein, which supports cancer cell growth and is overexpressed in many patients with mantle cell lymphoma. Venetoclax ...
CAR -T cell therapy has shown potential in achieving remission in some B-cell lymphomas and leukemias. Yet, challenges persist with cancer relapsing in ...
The primary purpose of this study is to assess the safety and effectiveness of ALLO-501A to treat patients with relapsed/refractory large B cell lymphoma (LBCL) ...
Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas · More about research at Mayo Clinic.
Low-grade lymphomas have an advantage in that they can take a very long ... B-Cell lymphoma. Journal of Hematopathology. 2019; doi:10.1007/s12308-019 ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.